First of all, most of the hospital companies are already trading at a huge premium. So, to that extent, making a case for further premium will be tougher. But that said, I agree with you that across the board, the results have been pretty decent. The top line growth is reasonable and profitability improvement is something which we have seen. And this is a space where the pricing power remains with many of these hospital chains.
